We have data on 34 companies that use SnpEff. The companies using SnpEff are most often found in United States and in the Higher Education industry. SnpEff is most often used by companies with >10000 employees and >1000M dollars in revenue. Our data for SnpEff usage goes back as far as 1 years and 2 months.
|UNIVERSITY OF PITTSBURGH||pitt.edu||United States||10M-50M||>10000|
|Guardant Health Inc||guardanthealth.com||United States||50M-100M||200-500|
|The Children's Hospital of Philadelphia||chop.edu||United States||>1000M||>10000|
|Cancer Genetics Inc||cancergenetics.com||United States||10M-50M||200-500|
|NEW YORK GENOME CENTER INC||nygenome.org||United States||100M-200M||200-500|
We use the best scanning techniques combined with advanced data science to monitor the market share of over 5,000 technology products, including Healthcare. In the Healthcare category, SnpEff has a market share of about 0.1%. Other major and competing products in this category include:
SnpEff is an open source tool that annotates variants and predicts their effects on genes by using an interval forest approach. This program takes pre-determined variants listed in a data file that contains the nucleotide change and its position and predicts if the variants are deleterious.
Looking at SnpEff customers by industry, we find that Higher Education (39%) and Hospital & Health Care (27%) are the largest segments.
83% of SnpEff customers are in United States.